Chief Executive Officer & Director of Technology Development
Juno Genetics US
New York, New York
Chaim Jalas serves as Chief Executive Officer & Director of Technology Development at Juno Genetics US. Juno Genetics US operates in the medical practice sector with approximately 20.0 employees. The company is headquartered in New York, New York.
Executives like Chaim Jalas in the medical practice sector receive targeted outreach from sales teams, recruiters, and investors. To stand out, personalize your message with industry-specific context and a clear, specific value proposition relevant to their role at Juno Genetics US.
Executive contact data compiled from public business filings, LinkedIn public profiles, company press materials, and verified outbound email testing. We do not publish personal addresses or sensitive identifiers. Methodology & sources · Removal requests handled at /remove-info · Updated July 2026.
Chaim Jalas's verified email address is available to MessageCEO Pro subscribers. They currently serve as Chief Executive Officer & Director of Technology Development at Juno Genetics US. Access direct contact info to skip gatekeepers and reach the decision maker.
Chaim Jalas is Chief Executive Officer & Director of Technology Development at Juno Genetics US, a company in the medical practice sector with 20.0 employees. The company is based in New York, New York.
As Chief Executive Officer & Director of Technology Development at Juno Genetics US, Chaim Jalas is a key decision-maker in the medical practice sector. MessageCEO Pro gives you verified email to reach Chaim Jalas directly — ideal for B2B sales, partnerships, and executive recruiting.
Chaim Jalas works in the medical practice industry as Chief Executive Officer & Director of Technology Development at Juno Genetics US. MessageCEO provides verified contact information for executives across all major industries.
Yes. MessageCEO verifies executive contact information through multiple data sources and regular validation checks. Chaim Jalas's profile is kept up-to-date with the latest available information.